Exhibit 99.1
Reconciliation of Non-GAAP Financial Measures
AMCC reports its financial results in accordance with accounting principles generally accepted in the United States (“GAAP”) and also provides additional financial data that have not been prepared in accordance with GAAP. The non-GAAP results and other financial measures reported by the Company exclude certain items that are required by GAAP, such as restructuring charges, amortization and impairments of purchased intangibles and goodwill, acquired in-process research and development charges, stock-based compensation charges, litigation settlement costs, realized gains on strategic equity investments, payroll tax on certain stock option exercises and expenses related to stock option investigation. Expenses related to stock option investigation consist primarily of fees paid to professional service firms in connection with the Company’s internal investigation of historical stock option grant practices and the resulting restatement of the Company’s financial statements, the investigations by the Securities and Exchange Commission and the U.S. Attorney’s office arising from the Company’s internal investigation and the defense of derivative lawsuits arising from the internal investigation. Income taxes are adjusted to an estimated non-GAAP effective tax rate. These non-GAAP measures are not a substitute for GAAP measures and may not be consistent with the presentation used by other companies. The Company uses the non-GAAP financial measures to evaluate and manage its operations. The Company is providing this information to allow investors to perform additional financial analysis and because it is consistent with the financial models and estimates published by analysts who follow the Company.
The tables that follow reconcile the historical non-GAAP results and other financial measures reported by the Company with the most directly comparable GAAP financial measures. The Company has not provided a reconciliation of forward-looking non-GAAP financial measures reported by the Company due to the difficulty in forecasting and quantifying the exact amount of certain items that will be excluded from the non-GAAP financial measures but included in the comparable GAAP financial measures when reported. These items, some of which are listed above, are dependent upon future market conditions and valuations that the Company cannot determine in advance.
Applied Micro Circuits Corporation
GAAP Consolidated Statements of Operations
(unaudited)
(in thousands, except per share data)
FY05 | FY06 | FY07 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Q1 | Q2 | Q3 | Q4 | FY05 | Q1 | Q2 | Q3 | Q4 | FY06 | Q1 | Q2 | FY07 YTD | ||||||||||||||||||||||||||||||||||||||||
Net revenues | $ | 67,402 | $ | 61,069 | $ | 61,081 | $ | 64,204 | $ | 253,756 | $ | 64,673 | $ | 64,935 | $ | 65,243 | $ | 66,993 | $ | 261,844 | $ | 69,679 | $ | 76,364 | $ | 146,043 | ||||||||||||||||||||||||||
Cost of revenues | 31,492 | 31,529 | 30,159 | 30,073 | 123,253 | 30,833 | 31,093 | 30,017 | 30,449 | 122,392 | 31,528 | 35,536 | 67,064 | |||||||||||||||||||||||||||||||||||||||
Gross profit | 35,910 | 29,540 | 30,922 | 34,131 | 130,503 | 33,840 | 33,842 | 35,226 | 36,544 | 139,452 | 38,151 | 40,828 | 78,979 | |||||||||||||||||||||||||||||||||||||||
Operating expenses: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Research and development | 30,990 | 31,702 | 31,411 | 24,562 | 118,665 | 22,974 | 23,161 | 22,775 | 22,170 | 91,080 | 22,839 | 24,853 | 47,692 | |||||||||||||||||||||||||||||||||||||||
Selling, general and administrative | 14,378 | 15,298 | 15,887 | 14,258 | 59,821 | 15,550 | 14,344 | 14,239 | 14,263 | 58,396 | 17,000 | 17,312 | 34,312 | |||||||||||||||||||||||||||||||||||||||
Stock-based compensation: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Research and development (1) | 1,032 | 915 | 752 | 708 | 3,407 | 696 | 674 | 654 | 666 | 2,690 | — | — | — | |||||||||||||||||||||||||||||||||||||||
Selling, general and administrative (1) | 1,323 | 2,202 | 876 | 858 | 5,259 | 785 | 783 | 783 | 1,410 | 3,761 | — | — | — | |||||||||||||||||||||||||||||||||||||||
Amortization of purchased intangibles | 1,557 | 1,962 | 1,833 | 1,608 | 6,960 | 1,267 | 1,107 | 1,107 | 1,107 | 4,588 | 1,107 | 1,188 | 2,295 | |||||||||||||||||||||||||||||||||||||||
Impairment of purchased intangibles | — | — | 27,330 | — | 27,330 | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
Impairment of goodwill | — | — | — | — | — | — | — | — | 131,216 | 131,216 | — | — | — | |||||||||||||||||||||||||||||||||||||||
In-process R&D charge | 13,400 | — | — | — | 13,400 | — | — | — | — | — | — | 13,300 | 13,300 | |||||||||||||||||||||||||||||||||||||||
Restructuring charges | — | 310 | 8,079 | 1,233 | 9,622 | — | 3,559 | 1,339 | 7,704 | 12,602 | 1,247 | 1,419 | 2,666 | |||||||||||||||||||||||||||||||||||||||
Litigation settlement, net | — | — | 28,900 | 350 | 29,250 | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
Total operating expenses | 62,680 | 52,389 | 115,068 | 43,577 | 273,714 | 41,272 | 43,628 | 40,897 | 178,536 | 304,333 | 42,193 | 58,072 | 100,265 | |||||||||||||||||||||||||||||||||||||||
Operating loss | (26,770 | ) | (22,849 | ) | (84,146 | ) | (9,446 | ) | (143,211 | ) | (7,432 | ) | (9,786 | ) | (5,671 | ) | (141,992 | ) | (164,881 | ) | (4,042 | ) | (17,244 | ) | (21,286 | ) | ||||||||||||||||||||||||||
Interest and other income, net | 5,281 | 4,530 | 4,780 | 4,108 | 18,699 | 3,404 | 3,537 | 4,940 | 3,992 | 15,873 | 3,365 | 3,429 | 6,794 | |||||||||||||||||||||||||||||||||||||||
Loss before income taxes | (21,489 | ) | (18,319 | ) | (79,366 | ) | (5,338 | ) | (124,512 | ) | (4,028 | ) | (6,249 | ) | (731 | ) | (138,000 | ) | (149,008 | ) | (677 | ) | (13,815 | ) | (14,492 | ) | ||||||||||||||||||||||||||
Income tax expense (benefit) | 335 | — | 2,526 | — | 2,861 | 176 | 175 | (1,315 | ) | 328 | (636 | ) | 140 | 74 | 214 | |||||||||||||||||||||||||||||||||||||
Net income (loss) | $ | (21,824 | ) | $ | (18,319 | ) | $ | (81,892 | ) | $ | (5,338 | ) | $ | (127,373 | ) | $ | (4,204 | ) | $ | (6,424 | ) | $ | 584 | $ | (138,328 | ) | $ | (148,372 | ) | $ | (817 | ) | $ | (13,889 | ) | $ | (14,706 | ) | ||||||||||||||
Income (Loss) per share: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Diluted income (loss) per share | $ | (0.07 | ) | $ | (0.06 | ) | $ | (0.27 | ) | $ | (0.02 | ) | $ | (0.41 | ) | $ | (0.01 | ) | $ | (0.02 | ) | $ | 0.00 | $ | (0.47 | ) | $ | (0.49 | ) | $ | (0.00 | ) | $ | (0.05 | ) | $ | (0.05 | ) | ||||||||||||||
Shares used in calculating diluted income (loss) per share | 311,519 | 310,128 | 307,729 | 308,448 | 309,456 | 306,327 | 305,476 | 299,049 | 294,442 | 300,841 | 291,178 | 281,762 | �� | 286,470 | ||||||||||||||||||||||||||||||||||||||
(1) | Stock-based compensation expense for these periods has been included within their natural classifications |
Applied Micro Circuits Corporation
Reconciliation of GAAP to Non-GAAP Net Income/Loss
(unaudited)
(in thousands, except per share data)
FY05 | FY06 | FY07 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Q1 | Q2 | Q3 | Q4 | FY05 | Q1 | Q2 | Q3 | Q4 | FY06 | Q1 | Q2 | FY07 YTD | ||||||||||||||||||||||||||||||||||||||||
GAAP net income/ loss | $ | (21,824 | ) | $ | (18,319 | ) | $ | (81,892 | ) | $ | (5,338 | ) | $ | (127,373 | ) | $ | (4,204 | ) | $ | (6,424 | ) | $ | 584 | $ | (138,328 | ) | $ | (148,372 | ) | $ | (817 | ) | $ | (13,889 | ) | $ | (14,706 | ) | ||||||||||||||
Adjustments: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation charges | 2,510 | 3,246 | 1,975 | 1,514 | 9,245 | 1,507 | 1,478 | 1,458 | 2,097 | 6,540 | 2,511 | 2,677 | 5,188 | |||||||||||||||||||||||||||||||||||||||
Amortization of purchased intangibles | 8,259 | 9,539 | 7,884 | 6,805 | 32,487 | 6,463 | 6,305 | 4,732 | 4,732 | 22,232 | 4,733 | 5,941 | 10,674 | |||||||||||||||||||||||||||||||||||||||
Impairments of purchased intangibles | — | — | 27,330 | — | 27,330 | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
Impairment of goodwill | — | — | — | — | — | — | — | — | 131,216 | 131,216 | — | — | — | |||||||||||||||||||||||||||||||||||||||
In-process R&D charge | 13,400 | — | — | — | 13,400 | — | — | — | — | — | — | 13,300 | 13,300 | |||||||||||||||||||||||||||||||||||||||
Restructuring charges | — | 310 | 8,079 | 1,233 | 9,622 | — | 3,559 | 1,339 | 7,704 | 12,602 | 1,247 | 1,419 | 2,666 | |||||||||||||||||||||||||||||||||||||||
Litigation settlement, net | — | — | 28,900 | 350 | 29,250 | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
Realized gains on strategic equity investments | — | — | — | — | — | — | — | (672 | ) | — | (672 | ) | — | — | — | |||||||||||||||||||||||||||||||||||||
Payroll taxes on certain stock option exercises | 2 | — | — | 10 | 12 | — | — | 1 | 2 | 3 | 1 | — | 1 | |||||||||||||||||||||||||||||||||||||||
Income tax adjustments | (255 | ) | 1,149 | 3,670 | (1,006 | ) | 3,558 | (691 | ) | (945 | ) | (2,663 | ) | (1,377 | ) | (5,676 | ) | (94 | ) | (212 | ) | (306 | ) | |||||||||||||||||||||||||||||
Expenses related to stock option investigation | — | — | — | — | — | — | — | — | — | — | 1,113 | 1,668 | 2,781 | |||||||||||||||||||||||||||||||||||||||
Total GAAP to non-GAAP adjustments | 23,916 | 14,244 | 77,838 | 8,906 | 124,904 | 7,279 | 10,397 | 4,195 | 144,374 | 166,245 | 9,511 | 24,793 | 31,523 | |||||||||||||||||||||||||||||||||||||||
Non-GAAP net income (loss) | $ | 2,092 | $ | (4,075 | ) | $ | (4,054 | ) | $ | 3,568 | $ | (2,469 | ) | $ | 3,075 | $ | 3,973 | $ | 4,779 | $ | 6,046 | $ | 17,873 | $ | 8,694 | $ | 10,904 | $ | 16,817 | |||||||||||||||||||||||
Income (loss) per share: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
GAAP loss per share | $ | (0.07 | ) | $ | (0.06 | ) | $ | (0.27 | ) | $ | (0.02 | ) | $ | (0.41 | ) | $ | (0.01 | ) | $ | (0.02 | ) | $ | 0.00 | $ | (0.47 | ) | $ | (0.49 | ) | $ | (0.00 | ) | $ | (0.05 | ) | $ | (0.05 | ) | ||||||||||||||
GAAP to non-GAAP adjustments | 0.08 | 0.05 | 0.26 | 0.03 | 0.40 | 0.02 | 0.03 | 0.01 | 0.49 | 0.55 | 0.03 | 0.09 | 0.11 | |||||||||||||||||||||||||||||||||||||||
Non-GAAP income (loss) per share | $ | 0.01 | $ | (0.01 | ) | $ | (0.01 | ) | $ | 0.01 | $ | (0.01 | ) | $ | 0.01 | $ | 0.01 | $ | 0.02 | $ | 0.02 | $ | 0.06 | $ | 0.03 | $ | 0.04 | $ | 0.06 | |||||||||||||||||||||||
Reconciliation of shares used in calculating thenon-GAAP income (loss) per share: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
GAAP diluted shares used | 311,519 | 310,128 | 307,729 | 308,448 | 309,456 | 306,327 | 305,476 | 299,049 | 294,442 | 300,841 | 291,178 | 281,762 | 286,470 | |||||||||||||||||||||||||||||||||||||||
Adjustment for dilutive securities | 6,808 | — | — | 1,972 | — | 1,030 | 1,680 | — | 2,119 | 1,690 | 948 | 824 | 886 | |||||||||||||||||||||||||||||||||||||||
Non-GAAP shares used in the EPS calculation | 318,327 | 310,128 | 307,729 | 310,420 | 309,456 | 307,357 | 307,156 | 299,049 | 296,561 | 302,531 | 292,126 | 282,586 | 287,356 | |||||||||||||||||||||||||||||||||||||||
Applied Micro Circuits Corporation
Schedule of Selected GAAP to Non-GAAP Adjustments
(unaudited)
(in thousands)
FY05 | FY06 | FY07 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Q1 | Q2 | Q3 | Q4 | FY05 | Q1 | Q2 | Q3 | Q4 | FY06 | Q1 | Q2 | FY07 YTD | ||||||||||||||||||||||||||||||||||||||||
REVENUES | $ | 67,401 | $ | 61,069 | $ | 61,081 | $ | 64,204 | $ | 253,755 | $ | 64,673 | $ | 64,935 | $ | 65,243 | $ | 66,993 | $ | 261,844 | $ | 69,679 | $ | 76,364 | $ | 146,043 | ||||||||||||||||||||||||||
GROSS PROFIT - | ||||||||||||||||||||||||||||||||||||||||||||||||||||
GAAP gross profit | $ | 35,910 | $ | 29,540 | $ | 30,922 | $ | 34,131 | $ | 130,503 | $ | 33,840 | $ | 33,842 | $ | 35,226 | $ | 36,544 | $ | 139,452 | $ | 38,151 | $ | 40,828 | $ | 78,979 | ||||||||||||||||||||||||||
Stock-based compensation expense | 155 | 129 | 347 | 43 | 674 | 26 | 21 | 21 | 21 | 89 | 134 | 157 | 291 | |||||||||||||||||||||||||||||||||||||||
Amortization of purchased intangibles | 6,702 | 7,577 | 6,051 | 5,197 | 25,527 | 5,196 | 5,198 | 3,625 | 3,625 | 17,644 | 3,626 | 4,753 | 8,379 | |||||||||||||||||||||||||||||||||||||||
Non-GAAP gross profit | $ | 42,767 | $ | 37,246 | $ | 37,320 | $ | 39,371 | $ | 156,704 | $ | 39,062 | $ | 39,061 | $ | 38,872 | $ | 40,190 | $ | 157,185 | $ | 41,911 | $ | 45,738 | $ | 87,649 | ||||||||||||||||||||||||||
GAAP gross margin | 53.3 | % | 48.4 | % | 50.6 | % | 53.2 | % | 51.4 | % | 52.3 | % | 52.1 | % | 54.0 | % | 54.5 | % | 53.3 | % | 54.8 | % | 53.5 | % | 54.1 | % | ||||||||||||||||||||||||||
Non-GAAP gross margin | 63.5 | % | 61.0 | % | 61.1 | % | 61.3 | % | 61.8 | % | 60.4 | % | 60.2 | % | 59.6 | % | 60.0 | % | 60.0 | % | 60.1 | % | 59.9 | % | 60.0 | % | ||||||||||||||||||||||||||
OPERATING EXPENSES - | ||||||||||||||||||||||||||||||||||||||||||||||||||||
GAAP operating expenses | $ | 62,680 | $ | 52,389 | $ | 115,068 | $ | 43,577 | $ | 273,714 | $ | 41,272 | $ | 43,628 | $ | 40,897 | $ | 178,536 | $ | 304,333 | $ | 42,193 | $ | 58,072 | $ | 100,265 | ||||||||||||||||||||||||||
Stock-based compensation expense | 2,355 | 3,117 | 1,628 | 1,566 | 8,666 | 1,481 | 1,457 | 1,437 | 2,076 | 6,451 | 2,377 | 2,520 | 4,897 | |||||||||||||||||||||||||||||||||||||||
Amortization of purchased intangibles | 1,557 | 1,962 | 1,833 | 1,608 | 6,960 | 1,267 | 1,107 | 1,107 | 1,107 | 4,588 | 1,107 | 1,188 | 2,295 | |||||||||||||||||||||||||||||||||||||||
Impairment of purchased intangibles | — | — | 27,330 | — | 27,330 | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
Impairment of goodwill | — | — | — | — | — | — | — | — | 131,216 | 131,216 | — | — | — | |||||||||||||||||||||||||||||||||||||||
Restructuring charges | — | 310 | 8,079 | 1,233 | 9,622 | — | 3,559 | 1,339 | 7,704 | 12,602 | 1,247 | 1,419 | 2,666 | |||||||||||||||||||||||||||||||||||||||
In-process R&D charge | 13,400 | — | — | — | 13,400 | — | — | — | — | — | — | 13,300 | 13,300 | |||||||||||||||||||||||||||||||||||||||
Payroll taxes on certain stock option exercises | 2 | — | — | 10 | 12 | — | — | 1 | 2 | 3 | 1 | — | 1 | |||||||||||||||||||||||||||||||||||||||
Litigation settlement, net | — | — | 28,900 | 350 | 29,250 | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
Expenses related to stock option investigation | — | — | — | — | — | — | — | — | — | — | 1,113 | 1,668 | 2,781 | |||||||||||||||||||||||||||||||||||||||
Non-GAAP operating expenses | $ | 45,366 | $ | 47,000 | $ | 47,298 | $ | 38,810 | $ | 178,474 | $ | 38,524 | $ | 37,505 | $ | 37,013 | $ | 36,431 | $ | 149,473 | $ | 36,348 | $ | 37,977 | $ | 74,325 | ||||||||||||||||||||||||||
GAAP operating margin as %age of revenue | -39.7 | % | -37.4 | % | -137.8 | % | -14.7 | % | -56.4 | % | -11.5 | % | -15.1 | % | -8.7 | % | -212.0 | % | -63.0 | % | -5.8 | % | -22.6 | % | -14.6 | % | ||||||||||||||||||||||||||
Non-GAAP operating margin as %age of revenue | -3.9 | % | -16.0 | % | -16.3 | % | 0.9 | % | -8.6 | % | 0.8 | % | 2.4 | % | 2.8 | % | 5.6 | % | 2.9 | % | 8.0 | % | 10.2 | % | 9.1 | % | ||||||||||||||||||||||||||
OTHER INCOME (EXPENSE), NET - | ||||||||||||||||||||||||||||||||||||||||||||||||||||
GAAP other income (expense), net | $ | 5,281 | $ | 4,530 | $ | 4,780 | $ | 4,108 | $ | 18,699 | $ | 3,404 | $ | 3,537 | $ | 4,940 | $ | 3,992 | $ | 15,873 | $ | 3,365 | $ | 3,429 | $ | 6,794 | ||||||||||||||||||||||||||
Realized gains on strategic equity investments | — | — | — | — | — | — | — | (672 | ) | — | (672 | ) | — | — | — | |||||||||||||||||||||||||||||||||||||
Non-GAAP other income (expense), net | $ | 5,281 | $ | 4,530 | $ | 4,780 | $ | 4,108 | $ | 18,699 | $ | 3,404 | $ | 3,537 | $ | 4,268 | $ | 3,992 | $ | 15,201 | $ | 3,365 | $ | 3,429 | $ | 6,794 | ||||||||||||||||||||||||||
Pre-tax net income (loss) as a %age of revenue—GAAP | -31.9 | % | -30.0 | % | -129.9 | % | -8.3 | % | -49.1 | % | -6.2 | % | -9.6 | % | -1.1 | % | -206.0 | % | -56.9 | % | -1.0 | % | -18.1 | % | -9.9 | % | ||||||||||||||||||||||||||
Pre-tax net income (loss) as a %age of revenue—Non-GAAP | 4.0 | % | -8.6 | % | -8.5 | % | 7.3 | % | -1.2 | % | 6.1 | % | 7.8 | % | 9.4 | % | 11.6 | % | 8.8 | % | 12.8 | % | 14.7 | % | 13.8 | % | ||||||||||||||||||||||||||
INCOME TAX EXPENSE (BENEFIT) - | ||||||||||||||||||||||||||||||||||||||||||||||||||||
GAAP income tax expense (benefit) | $ | 335 | $ | — | $ | 2,526 | $ | — | $ | 2,861 | $ | 176 | $ | 175 | $ | (1,315 | ) | $ | 328 | $ | (636 | ) | $ | 140 | $ | 74 | $ | 214 | ||||||||||||||||||||||||
Income tax adjustments | 255 | (1,149 | ) | (3,670 | ) | 1,006 | (3,558 | ) | 691 | 945 | 2,663 | 1,377 | 5,676 | 94 | 212 | 306 | ||||||||||||||||||||||||||||||||||||
Non-GAAP income tax expense (benefit) | $ | 590 | $ | (1,149 | ) | $ | (1,144 | ) | $ | 1,006 | $ | (697 | ) | $ | 867 | $ | 1,120 | $ | 1,348 | $ | 1,705 | $ | 5,040 | $ | 234 | $ | 286 | $ | 520 | |||||||||||||||||||||||
RESEARCH AND DEVELOPMENT - | ||||||||||||||||||||||||||||||||||||||||||||||||||||
GAAP research and development | $ | 32,022 | $ | 32,617 | $ | 32,163 | $ | 25,270 | $ | 122,072 | $ | 23,670 | $ | 23,835 | $ | 23,429 | $ | 22,836 | $ | 93,770 | $ | 22,839 | $ | 24,853 | $ | 47,692 | ||||||||||||||||||||||||||
Stock-based compensation expense | 1,032 | 915 | 752 | 708 | 3,407 | 696 | 674 | 654 | 666 | 2,690 | 1,069 | 1,028 | 2,097 | |||||||||||||||||||||||||||||||||||||||
Payroll taxes on certain stock option exercises | — | — | — | 7 | 7 | — | — | 1 | 1 | 2 | — | — | — | |||||||||||||||||||||||||||||||||||||||
Non-GAAP research and development | $ | 30,990 | $ | 31,702 | $ | 31,411 | $ | 24,555 | $ | 118,658 | $ | 22,974 | $ | 23,161 | $ | 22,774 | $ | 22,169 | $ | 91,078 | $ | 21,770 | $ | 23,825 | $ | 45,595 | ||||||||||||||||||||||||||
SELLING, GENERAL AND ADMINISTRATIVE - | ||||||||||||||||||||||||||||||||||||||||||||||||||||
GAAP selling, general and administrative | $ | 15,701 | $ | 17,500 | $ | 16,763 | $ | 15,116 | $ | 65,080 | $ | 16,335 | $ | 15,127 | $ | 15,022 | $ | 15,673 | $ | 62,157 | $ | 17,000 | $ | 17,312 | $ | 34,312 | ||||||||||||||||||||||||||
Stock-based compensation expense | 1,323 | 2,202 | 876 | 858 | 5,259 | 785 | 783 | 783 | 1,410 | 3,761 | 1,308 | 1,492 | 2,800 | |||||||||||||||||||||||||||||||||||||||
Payroll taxes on certain stock option exercises | 2 | — | — | 3 | 5 | — | — | — | 1 | 1 | 1 | — | 1 | |||||||||||||||||||||||||||||||||||||||
Expenses related to stock option investigation | — | — | — | — | — | — | — | — | — | — | 1,113 | 1,668 | 2,781 | |||||||||||||||||||||||||||||||||||||||
Non-GAAP selling, general and administrative | $ | 14,376 | $ | 15,298 | $ | 15,887 | $ | 14,255 | $ | 59,816 | $ | 15,550 | $ | 14,344 | $ | 14,239 | $ | 14,262 | $ | 58,395 | $ | 14,578 | $ | 14,152 | $ | 28,730 | ||||||||||||||||||||||||||
Applied Micro Circuits Corporation
GAAP Consolidated Balance Sheets and Other Metrics
(unaudited)
(in thousands, except inventory turns data)
FY05 | FY06 | FY07 | ||||||||||||||||||||||||||||||||||||||
Q1 | Q2 | Q3 | Q4 | Q1 | Q2 | Q3 | Q4 | Q1 | Q2 | |||||||||||||||||||||||||||||||
ASSETS | ||||||||||||||||||||||||||||||||||||||||
Current assets: | ||||||||||||||||||||||||||||||||||||||||
Cash, cash equivalents and short-term investments | $ | 475,252 | $ | 410,576 | $ | 405,970 | $ | 423,392 | $ | 379,371 | $ | 369,507 | $ | 350,810 | $ | 335,665 | $ | 336,110 | $ | 265,776 | ||||||||||||||||||||
Accounts receivable, net | 34,775 | 27,872 | 22,304 | 28,601 | 23,694 | 26,365 | 22,390 | 26,324 | 31,103 | 36,967 | ||||||||||||||||||||||||||||||
Inventories | 14,075 | 18,842 | 19,847 | 18,014 | 16,399 | 18,697 | 20,648 | 24,941 | 26,333 | 34,128 | ||||||||||||||||||||||||||||||
Other current assets | 15,100 | 17,362 | 46,623 | 51,448 | 15,585 | 14,937 | 14,999 | 12,618 | 14,918 | 14,436 | ||||||||||||||||||||||||||||||
Total current assets | 539,202 | 474,652 | 494,744 | 521,455 | 435,049 | 429,506 | 408,847 | 399,548 | 408,464 | 351,307 | ||||||||||||||||||||||||||||||
Intangible assets | 587,782 | 578,206 | 544,892 | 534,514 | 528,051 | 521,746 | 517,014 | 381,066 | 376,333 | 427,809 | ||||||||||||||||||||||||||||||
Property and equipment, net | 40,996 | 39,762 | 47,102 | 44,461 | 44,668 | 41,076 | 38,237 | 36,127 | 33,394 | 33,438 | ||||||||||||||||||||||||||||||
Other assets | 1,656 | 1,769 | 1,999 | 1,965 | 2,071 | 2,493 | 8,269 | 8,685 | 9,066 | 9,716 | ||||||||||||||||||||||||||||||
Total Assets | $ | 1,169,636 | $ | 1,094,389 | $ | 1,088,737 | $ | 1,102,395 | $ | 1,009,839 | $ | 994,821 | $ | 972,367 | $ | 825,426 | $ | 827,257 | $ | 822,270 | ||||||||||||||||||||
LIABILITIES & STOCKHOLDERS’ EQUITY | ||||||||||||||||||||||||||||||||||||||||
Current liabilities: | ||||||||||||||||||||||||||||||||||||||||
Accounts payable | $ | 25,385 | $ | 26,163 | $ | 14,164 | $ | 24,016 | $ | 19,747 | $ | 25,984 | $ | 28,268 | 24,656 | $ | 28,729 | $ | 29,673 | |||||||||||||||||||||
Accrued payroll and related expenses | 14,337 | 11,219 | 11,730 | 10,101 | 9,944 | 8,132 | 8,525 | 7,409 | 9,893 | 8,104 | ||||||||||||||||||||||||||||||
Other accrued liabilities | 33,085 | 29,565 | 94,030 | 87,107 | 20,466 | 20,345 | 21,289 | 27,017 | 24,809 | 24,819 | ||||||||||||||||||||||||||||||
Deferred revenue | 4,118 | 4,036 | 3,897 | 3,939 | 3,281 | 3,655 | 3,358 | 3,536 | 3,599 | 3,278 | ||||||||||||||||||||||||||||||
Current portion of long-term debt and capital lease obligations | 233 | 171 | 103 | 34 | 7 | — | — | — | — | — | ||||||||||||||||||||||||||||||
Total current liabilities | 77,158 | 71,154 | 123,924 | 125,197 | 53,445 | 58,116 | 61,440 | 62,618 | 67,030 | 65,874 | ||||||||||||||||||||||||||||||
Stockholders’ equity: | ||||||||||||||||||||||||||||||||||||||||
Common stock | 3,118 | 3,081 | 3,078 | 3,083 | 3,054 | 3,027 | 2,933 | 2,954 | 2,832 | 2,817 | ||||||||||||||||||||||||||||||
Deferred compensation | (19,463 | ) | (14,228 | ) | (10,978 | ) | (9,101 | ) | (7,507 | ) | (5,869 | ) | (4,377 | ) | (2,087 | ) | — | — | ||||||||||||||||||||||
Additional paid-in capital | 6,036,381 | 5,971,370 | 5,992,833 | 6,013,958 | 5,992,428 | 5,980,206 | 5,956,113 | 5,945,555 | 5,943,581 | 5,946,278 | ||||||||||||||||||||||||||||||
Retained earnings (deficit) | (4,918,326 | ) | (4,936,645 | ) | (5,018,537 | ) | (5,023,875 | ) | (5,028,079 | ) | (5,034,503 | ) | (5,033,919 | ) | (5,172,247 | ) | (5,173,064 | ) | (5,186,953 | ) | ||||||||||||||||||||
Accumulated other comprehensive income or loss | (9,232 | ) | (343 | ) | (1,583 | ) | (6,867 | ) | (3,502 | ) | (6,156 | ) | (9,823 | ) | (11,367 | ) | (13,122 | ) | (5,746 | ) | ||||||||||||||||||||
Total stockholders’ equity | 1,092,478 | 1,023,235 | 964,813 | 977,198 | 956,394 | 936,705 | 910,927 | 762,808 | 760,227 | 756,396 | ||||||||||||||||||||||||||||||
Total Liabilities and Stockholders’ Equity | $ | 1,169,636 | $ | 1,094,389 | $ | 1,088,737 | $ | 1,102,395 | $ | 1,009,839 | $ | 994,821 | $ | 972,367 | $ | 825,426 | $ | 827,257 | $ | 822,270 | ||||||||||||||||||||
GAAP inventory turns | 8.9 | 6.7 | 6.1 | 6.7 | 7.5 | 6.7 | 5.8 | 4.9 | 4.8 | 4.2 | ||||||||||||||||||||||||||||||
Non-GAAP inventory turns | 7.0 | 5.1 | 4.8 | 5.5 | 6.2 | 5.5 | 5.1 | 4.3 | 4.2 | 3.3 |
5